Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)
Egypt flag Egypt · Delayed Price · Currency is EGP
1.490
-0.030 (-1.97%)
At close: Aug 5, 2026

EGX:MCRO Cash Flow Statement

Millions EGP. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
115.73-38.1-272.65173.84147.93
Depreciation & Amortization
17.1316.5616.7213.626.6
Other Amortization
0.380.380.510.68-
Loss (Gain) From Sale of Assets
-0.330.02--
Asset Writedown & Restructuring Costs
--24.42--
Loss (Gain) From Sale of Investments
--3.29---
Provision & Write-off of Bad Debts
29.5835.6898.433.150.5
Other Operating Activities
31.3737.0347.8720.520.47
Change in Accounts Receivable
-1.33-168.85104.94-33.58-131.35
Change in Inventory
-20.1520.44-67.65-73.12-19.33
Change in Accounts Payable
44.68-18.5720.2527.7416.69
Change in Other Net Operating Assets
-56.443.94-10.872.18.74
Operating Cash Flow
160.99-74.45-38.01134.9350.26
Operating Cash Flow Growth
---168.47%9.39%

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-42.48-12.32-6.44-5.3-5.81
Sale of Property, Plant & Equipment
0.62-0.04--
Cash Acquisitions
-----1.5
Sale (Purchase) of Intangibles
----3.5-
Investment in Securities
-3.29---
Other Investing Activities
9.395.771.982.81.5
Investing Cash Flow
-32.46-3.26-4.42-6.01-5.82

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
97.37226.81293.77286.337.25
Long-Term Debt Issued
102.58154.63---
Total Debt Issued
199.95381.45293.77286.337.25
Short-Term Debt Repaid
-196.4-317.81-260.57-212.08-
Long-Term Debt Repaid
-18.37-16.01-12.25-11.88-4.58
Total Debt Repaid
-214.78-333.83-272.82-223.96-4.58
Net Debt Issued (Repaid)
-14.8247.6220.9562.372.67
Issuance of Common Stock
-21.82---
Repurchase of Common Stock
---29.97-24.87-
Common Dividends Paid
--4.7-60-40-46.82
Financing Cash Flow
-14.8264.73-69.02-2.5-44.15

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
113.7-12.97-111.44126.430.29

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
118.51-86.76-44.44129.6344.44
Free Cash Flow Growth
---191.66%14.31%
Free Cash Flow Margin
13.25%-16.69%-8.45%17.77%7.48%
Free Cash Flow Per Share
0.21-0.15-0.080.230.08
Levered Free Cash Flow
67.9-99.4284.4275.76-1
Unlevered Free Cash Flow
89.42-61.51102.8584.184.1

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
27.3732.2225.2710.146.26
Cash Income Tax Paid
0.10.0548.7945.7142.95
Change in Working Capital
-33.21-123.0446.67-76.86-125.25